Heat shock protein 70-associated peptides elicit specific cancer immunity

Heiichiro Udono, Pramod K. Srivastava

Research output: Contribution to journalArticlepeer-review

568 Citations (Scopus)


Vaccination of mice with heat shock protein 70 (hsp70) preparations derived from the Meth A sarcoma, but not from normal tissues, renders the mice immune to a substantial challenge with Meth A sarcoma. The immunogenicity is dose dependent and tumor specific. Treatment of an antigenically active hsp70 preparation with ATP followed by removal of low-molecular weight material leaves hsp70 intact, as judged by SDS-PAGE but results in loss of antigenicity, as judged by tumor rejection assays. Separation of this low-molecular weight material on a C18 reverse-phase column shows a diverse array of peptides with molecular mass between 1,000 and 5,000 daltons. Our data indicate that antigenicity of hsp70 preparations derives, not from hsp70 per se, but from associated peptides. These observations may suggest a novel method of using the peptide-binding property of hsp70 for specific vaccination against cancer and infectious diseases.

Original languageEnglish
Pages (from-to)1393-1396
Number of pages4
JournalJournal of Experimental Medicine
Issue number4
Publication statusPublished - Oct 1 1993
Externally publishedYes

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology


Dive into the research topics of 'Heat shock protein 70-associated peptides elicit specific cancer immunity'. Together they form a unique fingerprint.

Cite this